Concepedia

Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization

Emiliano S. López, Manglio Rizzo, J. Oscar Croxatto, Guillermo Mazzolini, Juan E. Gallo

Cancer Chemotherapy and Pharmacology · 2010 · 12 citations · 15 references

DOI

Concepts

References

15

Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular Neovascularization

Nobuo Jo, Carolina Mailhos, Meihua Ju et al. · American Journal Of Pathology · 2006 · 323 citations · Full text

, , +15

Risk Factors for Human Corneal Graft Failure Within the Australian Corneal Graft Registry

Marie Therese Lowe, Christine Mary Bartlett, Thu‐Lan Kelly et al. · Transplantation · 2008 · 243 citations

, , +17

Suramin: a novel antineoplastic agent with multiple potential mechanisms of action.

Christian Stein · PubMed · 1993 · 229 citations

, , +7

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

R. P A Manzano, Gholam A. Peyman, Palwasha Khan et al. · British Journal of Ophthalmology · 2006 · 221 citations · Full text

, , +17

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration

Andrew A. Moshfeghi, Philip J. Rosenfeld, Carmen A. Puliafito et al. · Ophthalmology · 2006 · 204 citations

, , +13